Novartis AG: Science-Based Business

Novartis AG: Science-Based Business Description

Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007, corporate R&D spending was $6.43B, or almost 17% of net sales. Novartis executive leaders believe in scientific progress and that large-scale investments in science will therefore result in long-term pay-offs in terms of profits and discoveries that benefit mankind. Novartis' business strategy is closely tied to its research strategy, which emphasizes extensive internal discovery and development capabilities leading to organic growth along with explicit external alliances and collaborations to supplement its core capabilities. Like its competitors, Novartis faces many challenges in terms of moving research from the bench to the bedside.a?? Five years after undertaking the restructuring of the discovery research organization, CEO Daniel Vasella is pleased with its progress, including many more development projects in the pipeline and new molecular entities. Nevertheless, the company faces a number of challenges, including generic drugs, patent infringements in developing countries, and pricing pressure from governments and health insurers in the United States. Given these challenges, Novartis must decide how much to spend on R&D overall, how to arrive at the right mix between organic growth and external collaboration and in-licensing, and how to measure success when it takes so many years to develop and launch a successful drug.a??a??a??a??

Case Description Novartis AG: Science-Based Business

Strategic Managment Tools Used in Case Study Analysis of Novartis AG: Science-Based Business

STEP 1. Problem Identification in Novartis AG: Science-Based Business case study

STEP 2. External Environment Analysis - PESTEL / PEST / STEP Analysis of Novartis AG: Science-Based Business case study

STEP 3. Industry Specific / Porter Five Forces Analysis of Novartis AG: Science-Based Business case study

STEP 4. Evaluating Alternatives / SWOT Analysis of Novartis AG: Science-Based Business case study

STEP 5. Porter Value Chain Analysis / VRIO / VRIN Analysis Novartis AG: Science-Based Business case study

STEP 6. Recommendations Novartis AG: Science-Based Business case study

STEP 7. Basis of Recommendations for Novartis AG: Science-Based Business case study

Case Analysis of Novartis AG: Science-Based Business

Novartis AG: Science-Based Business is a Harvard Business (HBR) Case Study on Organizational Development , Texas Business School provides HBR case study assignment help for just $9. Texas Business School(TBS) case study solution is based on HBR Case Study Method framework, TBS expertise & global insights. Novartis AG: Science-Based Business is designed and drafted in a manner to allow the HBR case study reader to analyze a real-world problem by putting reader into the position of the decision maker. Novartis AG: Science-Based Business case study will help professionals, MBA, EMBA, and leaders to develop a broad and clear understanding of casecategory challenges. Novartis AG: Science-Based Business will also provide insight into areas such as – wordlist , strategy, leadership, sales and marketing, and negotiations.

Case Study Solutions Background Work

Novartis AG: Science-Based Business case study solution is focused on solving the strategic and operational challenges the protagonist of the case is facing. The challenges involve – evaluation of strategic options, key role of Organizational Development, leadership qualities of the protagonist, and dynamics of the external environment. The challenge in front of the protagonist, of Novartis AG: Science-Based Business, is to not only build a competitive position of the organization but also to sustain it over a period of time.

Strategic Management Tools Used in Case Study Solution

The Novartis AG: Science-Based Business case study solution requires the MBA, EMBA, executive, professional to have a deep understanding of various strategic management tools such as SWOT Analysis, PESTEL Analysis / PEST Analysis / STEP Analysis, Porter Five Forces Analysis, Go To Market Strategy, BCG Matrix Analysis, Porter Value Chain Analysis, Ansoff Matrix Analysis, VRIO / VRIN and Marketing Mix Analysis.

Texas Business School Approach to Organizational Development Solutions

In the Texas Business School, Novartis AG: Science-Based Business case study solution – following strategic tools are used - SWOT Analysis, PESTEL Analysis / PEST Analysis / STEP Analysis, Porter Five Forces Analysis, Go To Market Strategy, BCG Matrix Analysis, Porter Value Chain Analysis, Ansoff Matrix Analysis, VRIO / VRIN and Marketing Mix Analysis.

We have additionally used the concept of supply chain management and leadership framework to build a comprehensive case study solution for the case – Novartis AG: Science-Based Business

Step 1 – Problem Identification of Novartis AG: Science-Based Business - Harvard Business School Case Study

The first step to solve HBR Novartis AG: Science-Based Business case study solution is to identify the problem present in the case. The problem statement of the case is provided in the beginning of the case where the protagonist is contemplating various options in the face of numerous challenges that Novartis A is facing right now. Even though the problem statement is essentially – “Organizational Development” challenge but it has impacted by others factors such as communication in the organization, uncertainty in the external environment, leadership in Novartis A, style of leadership and organization structure, marketing and sales, organizational behavior, strategy, internal politics, stakeholders priorities and more.

Step 2 – External Environment Analysis

Texas Business School approach of case study analysis – Conclusion, Reasons, Evidences - provides a framework to analyze every HBR case study. It requires conducting robust external environmental analysis to decipher evidences for the reasons presented in the Novartis AG: Science-Based Business.

The external environment analysis of Novartis AG: Science-Based Business will ensure that we are keeping a tab on the macro-environment factors that are directly and indirectly impacting the business of the firm.

What is PESTEL Analysis? Briefly Explained

PESTEL stands for political, economic, social, technological, environmental and legal factors that impact the external environment of firm in Novartis AG: Science-Based Business case study. PESTEL analysis of " Novartis AG: Science-Based Business" can help us understand why the organization is performing badly, what are the factors in the external environment that are impacting the performance of the organization, and how the organization can either manage or mitigate the impact of these external factors.

How to do PESTEL / PEST / STEP Analysis? What are the components of PESTEL Analysis?

As mentioned above PESTEL Analysis has six elements – political, economic, social, technological, environmental, and legal. All the six elements are explained in context with Novartis AG: Science-Based Business macro-environment and how it impacts the businesses of the firm.

How to do PESTEL Analysis for Novartis AG: Science-Based Business

To do comprehensive PESTEL analysis of case study – Novartis AG: Science-Based Business , we have researched numerous components under the six factors of PESTEL analysis.

Political Factors that Impact Novartis AG: Science-Based Business

Political factors impact seven key decision making areas – economic environment, socio-cultural environment, rate of innovation & investment in research & development, environmental laws, legal requirements, and acceptance of new technologies.

Policy Making Impact on Novartis AG: Science-Based Business

Government policies have significant impact on the business environment of any country. The firm in “ Novartis AG: Science-Based Business ” needs to navigate these policy decisions to create either an edge for itself or reduce the negative impact of the policy as far as possible.

Data safety laws – The countries in which Novartis A is operating, firms are required to store customer data within the premises of the country. Novartis A needs to restructure its IT policies to accommodate these changes. In the EU countries, firms are required to make special provision for privacy issues and other laws.

Competition Regulations – Numerous countries have strong competition laws both regarding the monopoly conditions and day to day fair business practices. Novartis AG: Science-Based Business has numerous instances where the competition regulations aspects can be scrutinized.

Import restrictions on products – Before entering the new market, Novartis A in case study Novartis AG: Science-Based Business" should look into the import restrictions that may be present in the prospective market.

Export restrictions on products – Apart from direct product export restrictions in field of technology and agriculture, a number of countries also have capital controls. Novartis A in case study “ Novartis AG: Science-Based Business ” should look into these export restrictions policies.

Foreign Direct Investment Policies – Government policies favors local companies over international policies, Novartis A in case study “ Novartis AG: Science-Based Business ” should understand in minute details regarding the Foreign Direct Investment policies of the prospective market.

Taxation & Regulation Impact on Novartis AG: Science-Based Business

Corporate Taxes – The rate of taxes is often used by governments to lure foreign direct investments or increase domestic investment in a certain sector. Corporate taxation can be divided into two categories – taxes on profits and taxes on operations. Taxes on profits number is important for companies that already have a sustainable business model, while taxes on operations is far more significant for companies that are looking to set up new plants or operations.

Tariffs – Chekout how much tariffs the firm needs to pay in the “ Novartis AG: Science-Based Business ” case study. The level of tariffs will determine the viability of the business model that the firm is contemplating. If the tariffs are high then it will be extremely difficult to compete with the local competitors. But if the tariffs are between 5-10% then Novartis A can compete against other competitors.

Government Scheme & Subsidies Impact on Novartis AG: Science-Based Business

Research and Development Subsidies and Policies – Governments often provide tax breaks and other incentives for companies to innovate in various sectors of priority. Managers at Novartis AG: Science-Based Business case study have to assess whether their business can benefit from such government assistance and subsidies.

Consumer protection – Different countries have different consumer protection laws. Managers need to clarify not only the consumer protection laws in advance but also legal implications if the firm fails to meet any of them.

Political System & Stability, and its Impact on Novartis AG: Science-Based Business

Political System and Its Implications – Different political systems have different approach to free market and entrepreneurship. Managers need to assess these factors even before entering the market.

Freedom of Press is critical for fair trade and transparency. Countries where freedom of press is not prevalent there are high chances of both political and commercial corruption.

Corruption level – Novartis A needs to assess the level of corruptions both at the official level and at the market level, even before entering a new market. To tackle the menace of corruption – a firm should have a clear SOP that provides managers at each level what to do when they encounter instances of either systematic corruption or bureaucrats looking to take bribes from the firm.

Independence of judiciary – It is critical for fair business practices. If a country doesn’t have independent judiciary then there is no point entry into such a country for business.

Government attitude towards trade unions – Different political systems and government have different attitude towards trade unions and collective bargaining. The firm needs to assess – its comfort dealing with the unions and regulations regarding unions in a given market or industry. If both are on the same page then it makes sense to enter, otherwise it doesn’t.

Economic Factors that Impact Novartis AG: Science-Based Business

Social Factors that Impact Novartis AG: Science-Based Business

Technological Factors that Impact Novartis AG: Science-Based Business

Environmental Factors that Impact Novartis AG: Science-Based Business

Legal Factors that Impact Novartis AG: Science-Based Business

Step 3 – Industry Specific Analysis

What is Porter Five Forces Analysis

PESTEL stands for political, economic, social, technological, environmental and legal factors that impact the external environment of firm in Novartis AG: Science-Based Business case study. PESTEL analysis of " Novartis AG: Science-Based Business" can help us understand why the organization is performing badly, what are the factors in the external environment that are impacting the performance of the organization, and how the organization can either manage or mitigate the impact of these external factors.

Step 4 – SWOT Analysis / Internal Environment Analysis

Step 5 – Porter Value Chain / VRIO / VRIN Analysis

Step 6 – Evaluating Alternatives & Recommendations

Step 7 – Basis for Recommendations

References :: Novartis AG: Science-Based Business case study solution